İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2021 · article

Everolimus treatment in a 3-month-old infant with tuberous sclerosis complex cardiac rhabdomyoma, severe left ventricular outflow tract obstruction, and hearing loss

ISSN1047-9511
YÖKSİS OpenAlex
Yıl2021
Atıf3OpenAlex
Yüzdelik%48,5
FWCI0,231,00 = dünya ortalaması
Scopus (SJR)Q3
WoS (JCR)Q4

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıCardiology in the Young
  • Katalog eşleşmesi (ISSN)Cardiology in the Young
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

Tuberous sclerosis complex is a rare multisystem genetic disorder characterised by the growth of numerous tumour-like malformations in many parts of the body including skin, kidneys, brain, lung, eyes, liver, and heart. Mutations in the TSC1 or TSC2 genes have been reported to cause disruption in the TSC1-TSC2 intracellular protein complex, causing over-activation of the mammalian target of rapamycin protein complex. In this study, we present a 3-month-old male infant diagnosed with tuberous sclerosis, bilateral neurosensorial hearing loss, Wolff-Parkinson-White syndrome on electrocardiography, multiple cardiac rhabdomyomas with severe stenosis in the left ventricular outflow tract, who responded well to the Everolimus therapy.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

3atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 5 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2023 Cardiac rhabdomyomas: clinical progression, efficacy and safety of everolimus treatmentAtıf 12 · OpenAlex
  2. 2023 Cardiac rhabdomyomas: clinical progression, efficacy and safety of everolimus treatmentAtıf 12 · OpenAlex
  3. 2023 Cardiac rhabdomyomas: clinical progression, efficacy and safety of everolimus treatmentAtıf 12 · OpenAlex
  4. 2023 Cardiac rhabdomyomas: clinical progression, efficacy and safety of everolimus treatmentAtıf 12 · OpenAlex
  5. 2023 Cardiac rhabdomyomas: clinical progression, efficacy and safety of everolimus treatmentAtıf 12 · OpenAlex

Yazarlar

3
  1. MECNUN ÇETİN 1
  2. AYSUN AYDIN SANCAROĞLU 2
  3. KAMURAN KARAMAN VAN YÜZÜNCÜ YIL ÜNİVERSİTESİ 3